TrialJAMA network open2023

Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.

Patricia Fanlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.